TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,318.22+0.21%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.50+0.34%Gold$4,142.51+0.04%Brent$109.81+0.54%BTC$81,998.91+0.19%ETH$2,409.93+0.20%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,318.22+0.21%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.50+0.34%Gold$4,142.51+0.04%Brent$109.81+0.54%BTC$81,998.91+0.19%ETH$2,409.93+0.20%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Charles River Laboratories International Inc · Overview · TradingHolo

Markets › United States › NYSE › CRL

C

Charles River Laboratories International Inc

NYSE:CRLHealthcareCBOE:SPESGNASDAQ:NQUSMG

$300.02−0.04%At closeAt close · Tue 20 Oct · ≈ AED 1,101.82 · Market cap $14.32B · Next earnings Wed 4 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−0.0%

1M

+7.9%

3M

+36.7%

6M

+61.7%

1Y

+71.5%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

CRL −0.04% today

✦ This week in three lines

No written digest yet for CRL. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +6.5%

Valuation

P/E vs sector−99.2× vs −1.7×

Price / Book vs sector4.5× vs 2.0×

Price / Sales vs sector3.6× vs 4.0×

Price / Free cash flow vs sector27.6× vs −1.6×

Forecasts

15 buy4 hold2 sell21 analysts

Average target$289.50 −3.5%

Analysts6

EPS surprises, last 87 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All CRL news →

DOCharles River Labs Is Maintained at Overweight by Morgan Stanley

Dow Jones Newswires · 7 d ago

BUCharles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development

BusinessWire · 7 d ago

TRCharles River Laboratories International, Inc. (CRL) Partners With Magellan Stem Cells on CGT Testing

TradingView · 7 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$14.32B

P/E−99.2×

Dividend yield0.0%

52-week range$146.20 – $333.30

Avg volume (20d)973,405

Shares outstanding47,738,900

Beta1.38

Short interest6.1% of float

Next earningsWed 4 Nov

Radar Score

66

Value56

Quality74

Momentum89

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing,…

SectorHealthcare

IndustryNormal

ExchangeNYSE

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×+1.36%